PFG Investments’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$207K Buy
+4,910
New +$156K 0.01% 1156
2024
Q2
– Sell
-7,843
Closed -$226K – 947
2024
Q1
$226K Buy
+7,843
New +$236K 0.01% 851
2023
Q3
– Sell
-7,463
Closed -$254K – 513
2023
Q2
$254K Buy
7,463
+608
+9% +$19.1K 0.05% 412
2023
Q1
$206K Buy
+6,855
New +$212K 0.04% 434

Other funds holding ARKG

PFG Investments's ARKG Position: Q2 2026 in Review

PFG Investments opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 4,910 shares worth $207K. The stake represents 0.01% of the portfolio and ranks #1156 among its holdings. This is a return to the name: PFG Investments previously reported a position in ARKG as recently as Q1 2024.

PFG Investments first reported a position in ARKG in Q1 2023 and has held it in 4 quarters since. The position peaked at $254K in Q2 2023. 274 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • PFG Investments held 4,910 shares of ARK Genomic Revolution ETF worth $207K as of Q2 2026.
  • ARK Genomic Revolution ETF was a new PFG Investments position in Q2 2026.
  • ARK Genomic Revolution ETF made up 0.01% of PFG Investments's portfolio in Q2 2026, its #1156 holding.
  • PFG Investments first reported a position in ARK Genomic Revolution ETF in Q1 2023 and has held it in 4 quarters since.
  • PFG Investments's ARK Genomic Revolution ETF position peaked at $254K in Q2 2023.
  • 274 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.